Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiangbo Zhang

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Scientific Reports|January 20, 2025
FLT3 is associated with dendritic cell infiltration, tertiary lymphoid structure construction, and predict response to checkpoint inhibitors immunotherapy in solid cancersYongchang Tang, Hong Wang, Jiankun Zhang, et al.
Aging|September 9, 2021
Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironmentQingan Jia, Yaoyao Zhang, Binghui Xu, et al.
Optics Letters|October 15, 2024
C3SI-compact complementary compressed spectral imagingBingliang Chen, Qiuyu Yue, Xinyu Liu, et al.
Optics Express|October 7, 2021
Continuous-zoom bifocal metalens by mutual motion of cascaded bilayer metasurfaces in the visibleChang Wang, Yan Sun, Qiangbo Zhang, et al.
Scientific Reports|October 25, 2017
CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinomaQingan Jia, Tongchun Xue, Qiangbo Zhang, et al.
Optics Express|December 19, 2025
Edge-aware adaptive hyperspectral acquisition via synergistic dual-camera architectureBingliang Chen, Changwei Zhang, Yang Zhang, et al.
Molecular Cancer|January 15, 2014
YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinomaJian Kong, Fandong Kong, Jun Gao, et al.
Cancer Letters|December 14, 2023
Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2Binghui Xu, Qingan Jia, Xia Liao, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Scientific Reports|January 20, 2025
FLT3 is associated with dendritic cell infiltration, tertiary lymphoid structure construction, and predict response to checkpoint inhibitors immunotherapy in solid cancersYongchang Tang, Hong Wang, Jiankun Zhang, et al.
Aging|September 9, 2021
Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironmentQingan Jia, Yaoyao Zhang, Binghui Xu, et al.
Optics Letters|October 15, 2024
C3SI-compact complementary compressed spectral imagingBingliang Chen, Qiuyu Yue, Xinyu Liu, et al.
Optics Express|October 7, 2021
Continuous-zoom bifocal metalens by mutual motion of cascaded bilayer metasurfaces in the visibleChang Wang, Yan Sun, Qiangbo Zhang, et al.
Scientific Reports|October 25, 2017
CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinomaQingan Jia, Tongchun Xue, Qiangbo Zhang, et al.
Optics Express|December 19, 2025
Edge-aware adaptive hyperspectral acquisition via synergistic dual-camera architectureBingliang Chen, Changwei Zhang, Yang Zhang, et al.
Molecular Cancer|January 15, 2014
YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinomaJian Kong, Fandong Kong, Jun Gao, et al.
Cancer Letters|December 14, 2023
Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2Binghui Xu, Qingan Jia, Xia Liao, et al.
Pageof 2